QCM
RLAY icon

Quantinno Capital Management’s Relay Therapeutics RLAY Stock Holding History

Quantinno Capital Management’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$211K Buy
21,188
+3,911
+23% +$35K ﹤0.01% 3187
2025
Q4 		$146K Buy
17,277
+4,904
+40% +$35K ﹤0.01% 3099
2025
Q3 		$64.6K Buy
+12,373
New +$47.2K ﹤0.01% 2902

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Quantinno Capital Management's RLAY Position: Q1 2026 in Review

Quantinno Capital Management increased its Relay Therapeutics (RLAY) stake by 23% in Q1 2026, buying an estimated $35K and bringing the position to 21,188 shares worth $211K. The position accounts for ﹤0.01% of the portfolio, ranked #3187.

Quantinno Capital Management first reported a position in RLAY in Q3 2025 and has held it in 3 quarters since. 242 funds tracked by Wall St. Rank hold RLAY as of Q1 2026.

  • Quantinno Capital Management held 21,188 shares of Relay Therapeutics worth $211K as of Q1 2026.
  • Quantinno Capital Management bought 3,911 Relay Therapeutics shares in Q1 2026, an estimated $35K.
  • Relay Therapeutics made up ﹤0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #3187 holding.
  • Quantinno Capital Management first reported a position in Relay Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 242 funds tracked by Wall St. Rank held Relay Therapeutics as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.